Cocoon Biotech has entered into service agreements with Camargo Pharmaceutical Services to provide end-to-end regulatory consulting and strategic development services for Cocoon’s pipeline of products initially developed for the treatment of osteoarthritis. The first joint program will involve biocompatible silk fibroin loaded with a small molecule therapeutic, and will include pre-investigational new drug (pre-IND) meeting planning and preparations through to new drug application (NDA) su...